Rick Simpson Oil (RSO) in Jackson County, West Virginia: A Complete Guide by OilWell Cannabis

Why Jackson County Needs Honest RSO Education

Jackson County, nestled along the Ohio River with its rolling hills and tight-knit communities, faces the same health challenges as the rest of America — but often with fewer resources. Chronic pain, cancer, PTSD, and sleep disorders affect families across Ravenswood, Ripley, and the smaller towns that make up this county of about 28,000 people. When conventional medicine falls short, many in Jackson County turn to alternative options, including cannabis products like Rick Simpson Oil (RSO).

The problem? Most RSO information online is either outdated, unsafe, or overhyped. Jackson County deserves better.

That’s why we’re publishing this complete guide to RSO — specifically for Jackson County residents. We’ll cover what RSO actually is, how it evolved from Rick Simpson’s original vision, what the science says, and how modern formulations like OilWell’s multi-cannabinoid RSO offer a safer, more precise alternative. Most importantly, we’ll show you how Jackson County residents can access these products legally and responsibly.

The Rick Simpson Story: How RSO Became a Global Movement

Who Was Rick Simpson?

Rick Simpson wasn’t a doctor or scientist. He was a power engineer from Nova Scotia who, in 1997, suffered a serious head injury while working at a hospital. The aftermath left him with persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. When his doctor refused to consider cannabis as an option, Simpson took matters into his own hands.

In 2003, Simpson claimed that three bumps on his arm diagnosed as basal cell carcinoma disappeared after he applied concentrated cannabis oil. No independent medical verification or biopsy confirmation was ever published, but this personal experience became the origin story of Rick Simpson Oil (RSO).

The Crusade: Giving Oil Away for Free

After his 2003 experience, Simpson committed himself to making and distributing concentrated cannabis oil. He gave it away for free to cancer patients and others in his community, charging nothing. By his account, he helped people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, which framed his work as a grassroots challenge to pharmaceutical and governmental interests. The film became foundational in cannabis communities and remains one of the most widely shared cannabis advocacy films.

Legal Troubles and the Evolution of RSO

Simpson’s advocacy brought him into conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005 and again in 2009, charging him with cannabis cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe.

Despite his legal troubles, Simpson’s legacy is undeniable. He gave his oil away for free, urged people to make their own, and never patented his method. The term “RSO” became synonymous with full-spectrum cannabis oil, even as the product evolved far beyond what Simpson originally made.

Traditional RSO: What It Was and Why It Needed to Change

What Was Traditional RSO?

Traditional RSO was a crude, unstandardized cannabis extract made using naphtha or isopropyl alcohol as the solvent. Simpson’s method involved:

1. Placing cannabis plant material in a bucket.
2. Covering it with solvent and agitating to dissolve cannabinoids.
3. Filtering the solvent into a collection vessel.
4. Repeating the process with fresh solvent.
5. Evaporating the solvent in a rice cooker, leaving behind a thick, dark oil.
6. Transferring the oil into oral syringes for dosing.

The final product was nearly black, thick, tar-like, and had a strong cannabis odor. It was overwhelmingly THC-dominant (60-90% THC), with no terpenes (destroyed by heat and solvent) and no lab testing or standardization.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver 60 grams of concentrated cannabis oil over roughly 90 days. The protocol involved:

• Week 1: Half a grain of rice-sized dose (10-15 mg) three times daily.
• Weeks 2-5: Gradual dose escalation to 1 gram per day.
• Weeks 5-12: Maintaining 1 gram per day until the full 60 grams were consumed.
• Maintenance: 1-2 grams per month indefinitely.

At peak dosing, patients were consuming approximately 600-900 mg of delta-9 THC per day — far exceeding anything studied in controlled clinical settings.

The Problems with Traditional RSO

While Simpson’s intentions were noble, traditional RSO had significant limitations:

1. No Lab Testing or Standardization: Every batch was different, with unknown potency and potential contaminants.
2. Residual Solvent Risk: Naphtha and isopropyl alcohol are not food-grade solvents. Incomplete purging could leave harmful residues.
3. Extremely High THC Exposure: 600-900 mg of THC per day carries risks including severe intoxication, anxiety, panic, tachycardia, and cannabis use disorder.
4. No Terpenes: The heat and solvent process destroyed terpenes, which are now understood to play a role in the entourage effect.
5. No Minor Cannabinoids: Traditional RSO was THC-dominant, missing the potential benefits of CBD, CBG, CBN, and other compounds.
6. No Clinical Validation: Simpson’s claims about curing cancer were based on personal testimony, not controlled clinical trials.

The Evolution of RSO: From Crude Oil to Modern Formulations

How Modern RSO Differs from Traditional RSO

Modern RSO has evolved substantially from Simpson’s original vision. The table below highlights the key differences:

Why OilWell’s Formulas Diverge from Traditional RSO

OilWell’s RSO formulas are not traditional RSO. They are informed by the RSO tradition but depart from it in deliberate, evidence-motivated ways:

1. Multi-Cannabinoid Approach: Traditional RSO relied on whatever single strain the maker grew or sourced. OilWell’s formulas intentionally include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity.

2. Terpene Preservation and Addition: Traditional RSO had essentially no terpene content. OilWell includes live terpenes at 5% with a specific seven-terpene profile — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — because terpene bioactivity is plausible and supported at the preclinical level.

3. THCa as a Separate Ingredient: Traditional RSO fully decarboxylated everything, converting all THCa into delta-9 THC. OilWell’s sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity.

4. Reduced Delta-9 THC Dominance: Traditional RSO was overwhelmingly delta-9 THC. OilWell’s sublingual formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing the remaining cannabinoid content across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg). This reflects the broader cannabinoid research landscape rather than a single-compound dominance model.

5. Product Format Innovation: Simpson envisioned only one format: an oral oil administered from a syringe. OilWell offers both a 30 mL sublingual oil and a 1-gram vape cartridge, each with its own format-specific formulation acknowledging that different delivery routes have different pharmacokinetic profiles.

Solvent Safety and Extraction Evolution

One of the most significant improvements in modern RSO is solvent safety. Traditional RSO production used naphtha or isopropyl alcohol — neither of which is food-grade. Naphtha, in particular, is a complex petroleum hydrocarbon mixture that may contain benzene, toluene, and other toxic compounds.

Modern cannabis extraction overwhelmingly uses food-grade ethanol or supercritical carbon dioxide (CO₂). These methods allow for much more complete solvent removal, and the finished products can be tested for residual solvents using validated analytical methods. This eliminates the residual solvent risk that was a major safety concern with traditional RSO.

OilWell’s RSO is not an extraction product in the traditional sense. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha, no isopropyl alcohol, no butane — no extraction solvents are present in the finished product.

The Decarboxylation Choice: Patient-Controlled Potency

Traditional RSO was always fully decarboxylated. The heat of solvent evaporation converted all THCa into delta-9 THC, leaving the patient with no choice about psychoactivity — the oil was always psychoactive.

OilWell’s sublingual formula contains 1,500 mg of THCa in its acidic, non-psychoactive form. This creates three distinct usage options for the customer:

1. Raw, No Heat: All 1,500 mg stays as THCa — completely non-psychoactive. This option is compatible with work, driving, and daytime use with zero psychoactive impairment.
2. Fully Activated, Home Decarboxylation: Heating the oil at 260°F (125°C) for 45-60 minutes converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg of delta-9 THC, this yields approximately 1,405 mg of total delta-9 THC — achieving psychoactive potency comparable to traditional high-THC RSO.
3. Vape, Auto-Decarboxylation: The RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation.

This design puts the potency decision entirely in the customer’s hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing that principle through actual product chemistry rather than a one-size-fits-all approach.

Terpene Loss in Traditional RSO

Terpenes are volatile aromatic compounds with relatively low boiling points. Most cannabis terpenes begin to volatilize at temperatures between 21°C and 157°C, with many of the most abundant terpenes — including myrcene, limonene, and pinene — having boiling points below 180°C.

The traditional RSO production process destroyed terpenes in two ways: first, by dissolving them into the solvent wash along with cannabinoids; and second, by evaporating them off during the high-heat solvent-removal phase. This meant that traditional RSO was essentially a cannabinoid-only product, despite being derived from a terpene-rich plant.

OilWell’s formulas specify live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each of these terpenes has its own evidence profile, and the entourage-effect literature provides the theoretical framework for why preserving and including terpenes alongside cannabinoids may matter pharmacologically.

The Science Behind RSO: What the Evidence Says

Research Method and Evidence Weighting

When evaluating the science behind RSO, it’s important to use a clear evidence hierarchy:

1. Human Clinical Evidence: The strongest form of evidence, including randomized controlled trials (RCTs) and systematic reviews.
2. Systematic Reviews and Meta-Analyses: Comprehensive reviews that synthesize data from multiple studies.
3. Institutional Summaries: Statements from organizations like the National Institutes of Health (NIH) or the Food and Drug Administration (FDA).
4. Preclinical Literature: Animal studies, in vitro research, and mechanistic studies.

This hierarchy matters because the evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes are still much more dependent on reviews, animal work, or early translational literature.

Institutional Baseline from NIH and Related Sources

The National Center for Complementary and Integrative Health (NCCIH) states that the strongest established cannabinoid evidence is for:

• Certain rare epilepsies (e.g., Dravet syndrome, Lennox-Gastaut syndrome).
• Chemotherapy-related nausea and vomiting.
• Appetite or weight-loss indications associated with HIV/AIDS.

NCCIH also notes only modest evidence for chronic pain and multiple-sclerosis-related symptoms, with many other claimed uses still in early-stage research.

Safety concerns highlighted by NIH and institutional sources include:

• Impairment and motor vehicle crash risk.
• Cannabis use disorder.
• Pregnancy-related concerns.
• Accidental pediatric exposure.
• Contamination or labeling inaccuracy.
• THC-vape lung-injury concerns.

Cannabinoid Profiles: What the Science Says About Each Compound

OilWell’s RSO formula includes seven cannabinoids, each with its own evidence profile:

CBD (Cannabidiol) — 4,500 mg

• Evidence Profile: Strongest human evidence in the current formula set, especially when CBD is studied as a purified product.
• What Is Best Supported: Purified CBD has the most credible human evidence in seizure disorders (e.g., Epidiolex for Dravet syndrome and Lennox-Gastaut syndrome).
• Anxiety Research: A 2024 systematic review and meta-analysis covering 316 participants reported a statistically significant anxiolytic signal, but the authors stressed that the clinical sample remains limited.
• Pain Research: A 2024 systematic review concluded that the pain literature is promising but heterogeneous, with trial quality and consistency still limiting confidence in broad analgesic claims.
• Sleep Research: A 2023 insomnia review found that the literature remains methodologically weak, with many studies relying on nonvalidated subjective measures.
• Safety and Interaction Concerns: A 2023 systematic review found a real signal for liver enzyme elevation and possible drug-induced liver injury in some CBD contexts, especially in concentrated oral products and polypharmacy settings.

CBG (Cannabigerol) — 3,000 mg

• Evidence Profile: Mostly review-level and preclinical; human evidence remains sparse.
• Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids and appears pharmacologically distinct from both THC and CBD.
• Potential Research Areas: Published reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity.
• Caution: CBG is already being sold commercially while the evidence base remains thin.

Delta-8 THC — 6,000 mg

• Evidence Profile: Pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC.
• Comparative Pharmacology: Delta-8 THC and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior, but delta-8 THC appears less potent.
• Public-Health Literature: A 2023 scoping review found that much of the delta-8 evidence base is still dominated by animal studies, product chemistry, and public-health concerns.
• Manufacturing Context: Commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels.

THCa (Tetrahydrocannabinolic Acid) — 1,500 mg

• Evidence Profile: Important chemically and formulation-wise, but still low on direct human therapeutic evidence.
• What It Is: THCa is the acidic precursor of THC. It does not produce psychoactive effects unless decarboxylated by heat.
• Research Status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities.

Delta-9 THC — 90 mg

• Evidence Profile: Strongest human evidence of the psychoactive cannabinoids, but also the clearest adverse-effect burden.
• What Is Institutionally Best Supported: THC-containing cannabinoid medicines are relevant to chemotherapy-related nausea and vomiting, appetite and weight loss in HIV/AIDS, and some pain-related outcomes.
• Pain Evidence: A 2022 systematic review found that products with high THC content or roughly comparable THC:CBD ratios may provide short-term pain benefit, but they also increased dizziness, sedation, nausea, and treatment discontinuation.
• Mental-Health Risk: A 2025 systematic review found consistent unfavorable associations between high-concentration THC products and psychosis or schizophrenia outcomes.

CBN (Cannabinol) — 750 mg

• Evidence Profile: Weak human evidence; marketing has clearly moved ahead of the data.
• What It Is Often Marketed For: Sleep and sedation. That reputation is widespread, but the clinical support is far thinner than the market suggests.
• Best Direct Review for the Sleep Claim: A 2021 narrative review found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims for CBN.

CBC (Cannabichromene) — 750 mg

• Evidence Profile: Emerging, intriguing, and still overwhelmingly preclinical or review-based.
• Pharmacology and Therapeutic Interest: A 2024 focused review highlighted antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets.
• What the Older Literature Shows: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance.

Terpene Profiles: The Role of Aroma and Potential Bioactivity

OilWell’s RSO includes seven terpenes, each with its own evidence profile:

Limonene

• Evidence Profile: Largely review and preclinical.
• Potential Activity: Antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and immune-modulatory activities.
• Safety Note: Limonene oxidation products are clinically relevant contact allergens.

Myrcene

• Evidence Profile: Mostly preclinical, with very limited human evidence.
• Research Summary: Anxiolytic, antioxidant, anti-inflammatory, and analgesic properties.
• Interpretation Caution: Myrcene is often invoked as a proven sedating terpene, but that claim is stronger than the human evidence supports.

Caryophyllene (β-Caryophyllene)

• Evidence Profile: Among the most mechanistically interesting terpenes because of direct cannabinoid-system relevance.
• Why It Stands Out: β-Caryophyllene is a selective CB2 receptor agonist, which makes it especially relevant when discussing cannabis terpenes in pharmacologic terms.
• Research Themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, and gastroprotective actions.

Pinene

• Evidence Profile: Promising preclinical literature, weak human clinical confirmation.
• Brain-Health Framing: Antioxidant, anti-inflammatory, and neuroprotective signals that justify future study.

Linalool

• Evidence Profile: Similar to pinene: substantial preclinical interest, limited direct clinical confirmation.
• Research Summary: Stress, mood, and brain-health pharmacology.

Humulene

• Evidence Profile: Translationally interesting, but still early.
• Scoping-Review Findings: Broad preclinical evidence for anti-inflammatory and other biologic effects.

Terpinolene

• Evidence Profile: One of the least clinically characterized terpenes in this list.
• Systematic-Review Findings: A range of reported biological effects, but the evidence base is still dominated by in silico, in vitro, and animal studies.

Research Limits and Interpretation

When interpreting the science behind RSO, keep these key points in mind:

1. The Evidence Base Is Highly Uneven: CBD and delta-9 THC can support the most detailed human-facing statements; the rest require more caution.
2. Whole-Cannabis Extract Data, Purified-Molecule Data, Semisynthetic Cannabinoid Data, and Terpene-Only Data Are Not Interchangeable.
3. Minor Cannabinoids and Terpenes Are Commercially Interesting Precisely Because They Are Underexplored.
4. Product Quality Matters as Much as Molecule Identity: Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect interpretation.
5. For THCa in Particular, Chemistry Is Destiny: Storage and heating can change the actual exposure profile by converting acidic cannabinoids into neutral cannabinoids such as THC.

Common Overstatements to Avoid

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More Accurate: The specific sleep evidence for CBN remains weak and dated.
• Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
  More Accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited.
• Overstatement: Terpenes in general have proven entourage effects in patients.
  More Accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited.
• Overstatement: THCa is always nonpsychoactive.
  More Accurate: THCa itself is not THC, but heating and processing can convert THCa into THC.
• Overstatement: Delta-8 THC is safe because it is hemp-derived.
  More Accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns.

OilWell Cannabis: Bringing Modern RSO to Jackson County

The Origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — right across the river from Reynosa, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. Colin’s childhood was marked by exposure to violence, poverty, and limited opportunities. By sixteen, he had to leave home for good.

Despite the dangers, Colin chose cannabis over harder paths. He grew up in the traditional cannabis world pre-legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine. That combination — deep cannabis plant knowledge plus medical-grade technical precision — would eventually define OilWell’s approach.

Bentley’s Story: The Foundation of OilWell

The company’s origin story begins with a dog named Bentley. When Bentley fell seriously ill, veterinarians delivered the verdict: euthanasia was the only humane option. Bentley was paralyzed in his back legs, and pain medications would destroy his internal organs.

Colin refused to give up. He learned about CBD and created a specialized cannabinoid formula for pets — a golden paste. Bentley got up, walked over to Colin, and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball — this was not placebo effect. Dogs do not respond to placebo.

Bentley lived another ten years, passing naturally at age twenty. During those ten years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration: CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection.
• Dementia: CBC’s role in neurogenesis.
• Glaucoma: THC’s CB1 agonism for intraocular pressure reduction.
• Arthritis: Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone could not address neurodegeneration, dementia, glaucoma, and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical as Bentley aged. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Journey: From PTSD to Peace Gummies

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — using the cannabinoid knowledge he had developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD.

This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

ABC13 Houston: Seven Features Over Four Years

Between 2019 and 2023, ABC13 Houston (KTRK) — the ABC affiliate serving the fourth-largest city in the United States — featured Colin Valencia and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. No other Houston cannabis operator appears with that frequency or across that breadth of subject matter during the same period.

Key moments from the media record include:

• September 2019: Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”
• May 2021: Colin’s iconic honesty on Delta-8 THC: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”*
• August 2021: OilWell’s $35,000 COVID vaccine giveaway — 1,000 caviar pre-rolls donated to encourage vaccination.
• October 2021: Colin proactively removed all Delta-8 products from shelves when the ban was announced, warning other operators who were unknowingly shipping Schedule I narcotics.
• October 2022: The revelation that Colin has a personal marijuana conviction history, transforming the entire media record.

The OilWell RSO Philosophy

OilWell’s RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in deliberate, evidence-motivated ways. Four core principles define OilWell’s approach:

1. Accessibility Over Gatekeeping: No medical card is required. Anyone age 21 or older can purchase. OilWell ships nationwide and internationally.
2. Patient-Controlled Potency: THCa is sold in its acidic, non-psychoactive form. The customer decides whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency.
3. Open-Source Formulas: OilWell publishes their complete formulas publicly so that anyone who cannot afford the product can source ingredients and make their own version.
4. Evidence-Informed, Not Evidence-Overstating: The GENERAL KNOWLEDGE section in this document represents OilWell’s commitment to honest education about what the science actually says.

OilWell’s RSO Formulas: What’s Inside the Bottle

RSO Sublingual Oil — $129.99

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg
• Onset: 15-45 minutes (sublingual absorption)
• Peak Effects: 1-2 hours
• Duration: 4-6 hours

RSO Vape Cartridge — $49.99

• Live Terpenes: 5%+
• Format: 1-gram cartridge (510-thread universal battery compatibility)
• Onset: 1-2 minutes (fastest cannabinoid delivery method)
• Peak Effects: 10-15 minutes
• Duration: 2-4 hours

When to Use Each Format

Condition-Specific Usage Contexts for Jackson County Residents

Important Disclaimer: The following usage contexts are informed by cannabinoid research cited in this document and by OilWell’s formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

• Pre-Chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment.
• Acute Breakthrough Nausea: 2-3 vape puffs for immediate relief (1-2 minute onset).
• Post-Chemo: 0.5 mL sublingual every 6 hours as needed.
• Sleep Support During Treatment: 1.0 to 2.0 mL sublingual before bed (delivers 25-50 mg CBN).
• Evidence Context: Delta-8 THC antiemetic evidence, delta-9 THC nausea and vomiting evidence, CBD anxiolytic buffering.

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3 to 0.5 mL raw sublingual — provides anti-inflammatory cannabinoid exposure without psychoactive impairment.
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support.
• Breakthrough Pain: Vape as needed for rapid onset.
• Evidence Context: CBD pain evidence, delta-9 THC pain evidence, beta-caryophyllene CB2 agonism, THCa COX-2 inhibition.

Sleep Support

• Before Bed: 1.0 to 2.0 mL sublingual.
• At 2.0 mL: Delivers 50 mg CBN — the dosage level investigated in recent sleep literature.
• At 1.0 mL: Delivers 25 mg CBN — above the 20 mg threshold associated with reduced sleep disturbance in published research.
• Evidence Context: CBN sleep evidence, cannabis and sleep review literature.

Anxiety and Stress

• Daytime Functional Relief: 0.3 mL raw sublingual — CBD and CBG address anxiety-related pathways without psychoactive impairment.
• Nighttime: 1.0 mL sublingual — full cannabinoid profile including CBN for sleep architecture.
• Evidence Context: CBD anxiety evidence, CBG pharmacology, limonene entourage-effect evidence.

General Titration Principle

Start low, go slow. Begin with 0.25 to 0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

How Jackson County Residents Can Access OilWell RSO

Legal Framework: Farm Bill Compliance and THCa

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level in the United States. This legal framework is the foundation of OilWell’s RSO product design.

OilWell’s RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle — 3 mg per mL — well under the 0.3% threshold. All cannabinoids in the formula are hemp-derived. The product is legal under federal law and in West Virginia.

THCa — tetrahydrocannabinolic acid — is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

The practical significance of this framework is substantial. The customer can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg of delta-9 THC in the formula, this produces approximately 1,405 mg of total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at the customer’s discretion after purchase.

This means the same product can function as a non-psychoactive anti-inflammatory (used raw) or as a full-potency psychoactive cannabinoid product (after home decarboxylation). The customer controls the decision.

Important Legal Notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with their local laws regarding cannabinoid products. OilWell ships with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility.

Delivery and Shipping Options for Jackson County

OilWell offers multiple ways for Jackson County residents to access their RSO products:

Nationwide Shipping

• Coverage: All 50 states where Farm Bill-compliant products are legal, including West Virginia.
• Shipping Methods: USPS Priority Mail (2-3 business days), FedEx and UPS Ground (3-5 business days).
• Packaging: Discreet, with no cannabis branding visible.
• Tracking: Provided for all orders.
• Temperature Stability: Packaging designed to protect products during summer heat.
• Signature Option: Available for added security.

International Shipping

OilWell ships internationally and has already delivered to multiple countries. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at the point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

• Documentation: All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs purposes.
• Shipping Costs: Minimum flat-fee shipping applies; excessive international shipping costs are billed to the customer.
• Legal Responsibility: The customer is responsible for verifying legality in their jurisdiction and accepts all customs and legal risk.

Ordering Information

• Website: https://oilwellcbd.com/
• RSO Sublingual Oil: https://oilwellcbd.com/product/rick-simpson-oil-rso-sublingual-oil/
• RSO Vape Cartridge: https://oilwellcbd.com/product/1-gram-rick-simpson-oil-rso-vape/
• Complete RSO Guide: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
• Phone: (832) 416-2816
• Email: [email protected]

Open-Source Formulas: Make It Yourself If You Can’t Afford It

OilWell publishes their complete RSO formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford the product can source the individual cannabinoid distillates and isolates and make their own version.

RSO Sublingual Oil Open-Source Formula

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Base: Organic MCT oil

RSO Vape Cartridge Open-Source Formula

• Live Terpenes: 5%+

This is a direct echo of Rick Simpson’s original ethos. Simpson gave his oil away for free and taught people how to make it. OilWell adapted that ethos for the modern cannabinoid marketplace: they sell a professionally manufactured, lab-tested, standardized product for those who want it, and they publish the complete recipe for those who want to make it themselves.

Why Jackson County Should Choose OilWell RSO

Competitive Comparison: OilWell vs. Alternatives

The OilWell Difference: Why It Matters for Jackson County

1. Multi-Cannabinoid Synergy: Traditional RSO was THC-dominant. OilWell’s formula includes seven cannabinoids, each with its own evidence profile, creating a broader therapeutic potential.
2. Terpene Inclusion: Traditional RSO destroyed terpenes. OilWell includes live terpenes at 5% with a defined seven-terpene profile, enhancing both sensory experience and potential entourage effects.
3. Patient-Controlled Potency: Traditional RSO was always psychoactive. OilWell’s THCa preservation allows Jackson County residents to use the product non-psychoactively during the day and activate it for full potency at night.
4. Solvent-Free Production: Traditional RSO carried significant residual solvent risk. OilWell’s formulated blend uses no extraction solvents, eliminating that safety concern.
5. Lab Testing and Transparency: Traditional RSO had no lab testing. OilWell provides full panel testing and Certificates of Analysis.
6. Open-Source Formulas: Traditional RSO was a black box. OilWell publishes their complete formulas so Jackson County residents who can’t afford the product can make their own.
7. Nationwide and International Access: Traditional RSO was illegal to ship. OilWell’s Farm Bill-compliant THCa framework allows legal shipping to Jackson County and beyond.

Safety, Responsibility, and Legal Considerations for Jackson County

Safety First: What Jackson County Residents Need to Know

• Start Low, Go Slow: Begin with 0.25 to 0.5 mL sublingual and assess effects over 2-3 hours before increasing.
• Avoid Driving or Operating Machinery: While raw THCa is non-psychoactive, activated THC (from decarboxylation or vaping) can impair coordination and judgment.
• Drug Interactions: Cannabinoids can interact with medications, especially those metabolized by the liver. Consult your healthcare provider if you are taking prescription medications.
• Pregnancy and Nursing: Avoid cannabinoid products if you are pregnant or nursing.
• Keep Out of Reach of Children: Store products securely to prevent accidental ingestion.
• Consult Your Healthcare Provider: Especially important for Jackson County residents with underlying health conditions or those taking multiple medications.

Legal Status in West Virginia

• Federal Law: OilWell’s RSO is Farm Bill compliant, containing less than 0.3% delta-9 THC at the point of sale.
• West Virginia Law: Hemp-derived products containing less than 0.3% delta-9 THC are legal in West Virginia.
• THCa Considerations: THCa is not delta-9 THC. However, heating THCa converts it to delta-9 THC. Jackson County residents are responsible for understanding and complying with local laws regarding decarboxylation and use.
• Workplace Policies: Even non-psychoactive cannabinoids like THCa may trigger drug tests. Be aware of your employer’s policies.

Responsible Use: A Message for Jackson County

Cannabinoids can offer significant benefits, but they are not a cure-all. They should be used responsibly, in consultation with healthcare providers, and as part of a broader health and wellness strategy.

For Jackson County residents facing serious health challenges, we encourage you to:

• Consult Your Doctor: Discuss cannabinoid use with your healthcare provider, especially if you are undergoing treatment for cancer, chronic pain, or other serious conditions.
• Use Evidence-Informed Products: Choose products with lab testing, transparent labeling, and a clear evidence base.
• Start Low, Go Slow: Give your body time to adjust and find the right dose for your needs.
• Stay Informed: The science of cannabinoids is evolving. Stay up-to-date with the latest research and recommendations.

The Future of RSO in Jackson County

Rick Simpson’s legacy is one of advocacy, accessibility, and a deep belief in the power of cannabis to heal. OilWell’s mission is to honor that legacy while bringing it into the modern era — with science, transparency, and a commitment to serving communities like Jackson County.

The evolution of RSO from Simpson’s crude oil to OilWell’s multi-cannabinoid, lab-tested, open-source formulas reflects the broader evolution of the cannabis industry. What was once a fringe movement is now a legitimate, evidence-informed field with the potential to improve lives across Jackson County and beyond.

For Jackson County residents, this means access to better products, more information, and greater control over their health decisions. Whether you choose to purchase OilWell’s RSO or make your own using the open-source formulas, the most important thing is that you have the knowledge to make informed, responsible choices.

Final Thoughts: A New Era for RSO in Jackson County

RSO has come a long way since Rick Simpson first made his oil in Nova Scotia. From a crude, untested extract to a sophisticated, multi-cannabinoid formulation, RSO has evolved to meet the needs of modern patients. For Jackson County residents, this evolution means access to safer, more effective, and more transparent cannabis products.

OilWell Cannabis is proud to bring this evolution to Jackson County. Our commitment to evidence, transparency, and accessibility aligns with the values of this community — a place where people take care of each other, where hard work is respected, and where health and wellness are priorities.

We invite you to explore the world of modern RSO, to use the information in this guide to make informed decisions, and to join us in this new era of cannabis innovation. Whether you’re seeking relief from chronic pain, support during cancer treatment, help with sleep or anxiety, or simply a better understanding of cannabinoids, OilWell is here to serve Jackson County with integrity, science, and compassion.

Thank you for trusting us with your health and wellness journey. Together, we can bring the best of cannabis science to Jackson County — one drop, one puff, one informed decision at a time.